MargaretCooleyGarinMD

PubMed

• Predicting Responders to Reslizumab After 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic Asthma
  Margaret Garin, MD> ;American Journal of Respiratory and Critical Care Medicine. 2018 Oct 23
• Early decreases in blood eosinophil levels with reslizumab.
  Chanez, P.,McDonald, M.,Garin, M.,Murphy, K.> ;J. Allergy Clin. Immunol.. 2019 Jan 18
• Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
  Weinstein, S. F.,Katial, R. K.,Bardin, P.,Korn, S.,McDonald, M.,Garin, M.,Bateman, E. D.,Hoyte, FCL.,Germinaro, M.> ;J Allergy Clin Immunol Pract. 2018 Sep 09
• 10 citations
  Subclinical thyroid dysfunction and hip fracture and bone mineral density in older adults: the cardiovascular health study.
  Garin, M. C., Arnold, A. M., Lee, J. S., Robbins, J., Cappola, A. R.> ;The Journal of clinical endocrinology and metabolism. 2014 Jun 1
• 38 citations
  Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
  Garin, M. C., Highland, K. B., Silver, R. M., Strange, C.> ;The Journal of rheumatology. 2009 Feb 12
• 7 citations
  The spectrum of scleroderma lung disease.
  Highland, K. B., Garin, M. C., Brown, K. K.> ;Seminars in respiratory and critical care medicine. 2007 Sep 4
• Join now to see all